DEF 14AThe Ballot
Avalo Therapeutics, Inc. files DEF 14A
Filed Apr 27, 2021 · 5y ago · Accession 0001628280-21-007742
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- DEF 14A
- Filing date
- Apr 27, 2021
- Report date
- Jun 15, 2021
- Document
- cerecor-def14ax2021.htm
- Size
- 778 KB